Cargando…
PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428764/ http://dx.doi.org/10.1097/01.HS9.0000976904.28542.f2 |
| _version_ | 1785090547788021760 |
|---|---|
| author | Barcellini, Wilma Michel, Marc Cuker, Adam Cooper, Nichola Ghanima, Waleed Wong, Raymond Zaja, Francesco Zhang, Fengkui Bezlyak, Vladimir Nguyen, Thu Thuy Al-Samkari, Hanny |
| author_facet | Barcellini, Wilma Michel, Marc Cuker, Adam Cooper, Nichola Ghanima, Waleed Wong, Raymond Zaja, Francesco Zhang, Fengkui Bezlyak, Vladimir Nguyen, Thu Thuy Al-Samkari, Hanny |
| author_sort | Barcellini, Wilma |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428764 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287642023-08-17 PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT Barcellini, Wilma Michel, Marc Cuker, Adam Cooper, Nichola Ghanima, Waleed Wong, Raymond Zaja, Francesco Zhang, Fengkui Bezlyak, Vladimir Nguyen, Thu Thuy Al-Samkari, Hanny Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428764/ http://dx.doi.org/10.1097/01.HS9.0000976904.28542.f2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Barcellini, Wilma Michel, Marc Cuker, Adam Cooper, Nichola Ghanima, Waleed Wong, Raymond Zaja, Francesco Zhang, Fengkui Bezlyak, Vladimir Nguyen, Thu Thuy Al-Samkari, Hanny PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT |
| title | PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT |
| title_full | PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT |
| title_fullStr | PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT |
| title_full_unstemmed | PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT |
| title_short | PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT |
| title_sort | pb2552: vayhia: a randomized, double-blind, phase iii trial to assess the efficacy and safety of ianalumab vs placebo in patients with warm autoimmune hemolytic anemia that failed ≥1 line of treatment |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428764/ http://dx.doi.org/10.1097/01.HS9.0000976904.28542.f2 |
| work_keys_str_mv | AT barcelliniwilma pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT michelmarc pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT cukeradam pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT coopernichola pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT ghanimawaleed pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT wongraymond pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT zajafrancesco pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT zhangfengkui pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT bezlyakvladimir pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT nguyenthuthuy pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment AT alsamkarihanny pb2552vayhiaarandomizeddoubleblindphaseiiitrialtoassesstheefficacyandsafetyofianalumabvsplaceboinpatientswithwarmautoimmunehemolyticanemiathatfailed1lineoftreatment |